NL-OMON43121已完成不适用
Immunomonitoring of minimal residual autoimmunity using highly sensitive flow cytometry in ANCA-associated vasculitis patients treated with rituximab. - MORIA Study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) age 18 years,
- •2) established diagnosis of Anca-associated vasculitis (AAV) according to the treating physician
- •3) treatment with rituximab
排除标准
- •1) Have a history of a primary immunodeficiency
- •2) Have any other clinically significant abnormal laboratory value in the opinion of the investigator
研究者
相似试验
尚未招募
不适用
Evaluation of minimal residual disease,immune cells dynamics and quality of life in bortezomib based induction therapy followed by lenalidomide maintenance for newly diagnosed patients with multiple myeloma ineligible for stem cell transplantation.Multiple MyelomaJPRN-UMIN000014197Kyoto University Hematology Study Group40
招募中
不适用
Pathophysiological study for autoimmune dysregulation of hereditary angioedemaHereditary angioedemaJPRN-UMIN000010754Juntendo Hospital50
已完成
4 期
Analysis of immune status in autoimmune diseases treated with BiologicsAutoimmune diseasesJPRN-UMIN000012916Osaka University20
招募中
不适用
Immunomonitoring in immunosuppressed patients with pneumoniaC92.00Z94.81D90Z94.80DRKS00010546niversitätsklinikum Jena1,000
招募中
不适用
MOODSTRATIFICATION IMMUNOSTRATAPremature immune ageing to predict the effect of physical training intervention, in mood disordersF32F33F31Depressive episodeRecurrent depressive disorderBipolar affective disorderDRKS00022887niversitätsklinikum Münster500